Department of Neurology, Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon, France.
Stroke. 2013 Jul;44(7):1796-802. doi: 10.1161/STROKEAHA.113.000949. Epub 2013 May 7.
Reliable comparisons of stroke incidence are important. To determine the impact of systematic assessment of patients referred with transient ischemic attack on the measured incidence and severity of stroke, we compared 2 population-based studies.
Patients with first-ever stroke ascertained during 2006 through 2010 from the Dijon Stroke Registry and the Oxford Vascular (OXVASC) Study were studied. Both studies comply with the criteria for ideal incidence studies, but the OXVASC Study also systematically assessed all patients referred with transient ischemic attack. Stroke severity was measured by the National Institutes of Health Stroke Scale.
Among 902 incident strokes in Dijon and 748 cases in the OXVASC Study, age and gender distribution were comparable, but severity was lower in the OXVASC Study (median National Institutes of Health Stroke Scale, 2 versus 6; P<0.001). Although overall incidence of ischemic stroke was higher in the OXVASC Study (157 versus 98 of 100 000/y; incidence rate ratio, 1.59; 95% confidence interval, 1.24-2.05; P<0.001), this was accounted for by a 3-fold excess incidence of stroke with National Institutes of Health Stroke Scale ≤2 in the OXVASC Study (90 versus 29/100 000/y; P<0.001), with no difference in incidence of more severe ischemic stroke (incidence rate ratio, 0.95; 95% confidence interval, 0.68-1.33). Of all 660 incident ischemic strokes in the OXVASC Study, 375 (56.8%) cases had an National Institutes of Health Stroke Scale ≤2, of which 232 had been ascertained in the transient ischemic attack clinic. Of these 232 minor strokes, only 71 cases had a diagnosis of definite stroke documented in the medical records by the referring physician.
Reliance on routine clinical coding underestimates the incidence of minor stroke. To improve comparability of incidence studies, researchers should assess patients referred with transient ischemic attack, and all studies should stratify incidence rates by stroke severity.
可靠的卒中发病率比较十分重要。为了确定对短暂性脑缺血发作患者进行系统评估对测量的卒中发病率和严重程度的影响,我们比较了两项基于人群的研究。
研究对象为 2006 年至 2010 年期间在第戎卒中登记处和牛津血管研究(OXVASC)中首次确诊的首发卒中患者。这两项研究均符合理想发病率研究的标准,但 OXVASC 研究还对所有转诊的短暂性脑缺血发作患者进行了系统评估。卒中严重程度用国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)进行测量。
在第戎的 902 例和 OXVASC 研究的 748 例首发卒中患者中,年龄和性别分布相似,但 OXVASC 研究的严重程度较低(NIHSS 中位数为 2 分,而第戎为 6 分;P<0.001)。尽管 OXVASC 研究的总体缺血性卒中发病率较高(每 10 万人中为 157 例,而第戎为 98 例;发病率比值为 1.59,95%置信区间为 1.24~2.05;P<0.001),但这是由于 OXVASC 研究中 NIHSS≤2 的卒中发病率增加了 3 倍(90 例,每 10 万人中为 29 例;P<0.001),而严重程度更高的缺血性卒中的发病率没有差异(发病率比值为 0.95,95%置信区间为 0.68~1.33)。在 OXVASC 研究的所有 660 例首发缺血性卒中患者中,有 375 例(56.8%)的 NIHSS 评分≤2,其中 232 例在短暂性脑缺血发作诊所被发现。在这 232 例小卒中中,仅有 71 例由转诊医生在病历中记录了明确的卒中诊断。
依赖常规临床编码会低估小卒中的发病率。为了提高发病率研究的可比性,研究人员应评估转诊的短暂性脑缺血发作患者,并且所有研究都应根据卒中严重程度分层发病率。